These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12727954)

  • 1. Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.
    Iozzo P; Hallsten K; Oikonen V; Virtanen KA; Kemppainen J; Solin O; Ferrannini E; Knuuti J; Nuutila P
    J Clin Endocrinol Metab; 2003 May; 88(5):2055-60. PubMed ID: 12727954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
    Gastaldelli A; Toschi E; Pettiti M; Frascerra S; Quiñones-Galvan A; Sironi AM; Natali A; Ferrannini E
    Diabetes; 2001 Aug; 50(8):1807-12. PubMed ID: 11473042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
    Iozzo P; Hallsten K; Oikonen V; Virtanen KA; Parkkola R; Kemppainen J; Solin O; Lonnqvist F; Ferrannini E; Knuuti J; Nuutila P
    Diabetes Care; 2003 Jul; 26(7):2069-74. PubMed ID: 12832315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
    Cusi K; Consoli A; DeFronzo RA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4059-67. PubMed ID: 8923861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.
    Nuutila P; Knuuti J; Ruotsalainen U; Koivisto VA; Eronen E; Teräs M; Bergman J; Haaparanta M; Voipio-Pulkki LM; Viikari J
    Am J Physiol; 1993 May; 264(5 Pt 1):E756-62. PubMed ID: 8498497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of visceral fat accumulation in type 2 diabetes.
    Gastaldelli A; Miyazaki Y; Pettiti M; Matsuda M; Mahankali S; Santini E; DeFronzo RA; Ferrannini E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5098-103. PubMed ID: 12414878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects.
    Sjöstrand M; Holmäng A; Strindberg L; Lönnroth P
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1097-103. PubMed ID: 11052965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus.
    Borra R; Lautamäki R; Parkkola R; Komu M; Sijens PE; Hällsten K; Bergman J; Iozzo P; Nuutila P
    Metabolism; 2008 Oct; 57(10):1445-51. PubMed ID: 18803951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
    Iozzo P; Chareonthaitawee P; Dutka D; Betteridge DJ; Ferrannini E; Camici PG
    Diabetes; 2002 Oct; 51(10):3020-4. PubMed ID: 12351442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.
    Williams KV; Bertoldo A; Kinahan P; Cobelli C; Kelley DE
    Diabetes; 2003 Jul; 52(7):1619-26. PubMed ID: 12829624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.
    Cusi K; Cukier S; DeFronzo RA; Torres M; Puchulu FM; Redondo JC
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1410-7. PubMed ID: 11238540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy.
    Denne SC; Brechtel G; Johnson A; Liechty EA; Baron AD
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2371-7. PubMed ID: 7629232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.
    Hawkins M; Gabriely I; Wozniak R; Reddy K; Rossetti L; Shamoon H
    Diabetes; 2002 Jul; 51(7):2179-89. PubMed ID: 12086948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin action and skeletal muscle blood flow in patients with Type 1 diabetes and microalbuminuria.
    Wiggam MI; Hunter SJ; Ennis CN; Sheridan B; Atkinson AB; Bell PM
    Diabetes Res Clin Pract; 2001 Aug; 53(2):73-83. PubMed ID: 11403855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
    Bajaj M; Suraamornkul S; Pratipanawatr T; Hardies LJ; Pratipanawatr W; Glass L; Cersosimo E; Miyazaki Y; DeFronzo RA
    Diabetes; 2003 Jun; 52(6):1364-70. PubMed ID: 12765945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
    Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
    J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research.
    Basset-Sagarminaga J; van de Weijer T; Iozzo P; Schrauwen P; Schrauwen-Hinderling V
    Diabetologia; 2024 Mar; 67(3):407-419. PubMed ID: 38099962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
    Vaag A; Alford F; Beck-Nielsen H
    Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.